- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
72
72 companies
Axsome Therapeutics
Market Cap: US$6.2b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$125.17
7D
3.2%
1Y
34.3%
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€88.40
7D
8.7%
1Y
116.9%
Zevra Therapeutics
Market Cap: US$501.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.95
7D
-1.3%
1Y
22.3%
Camurus
Market Cap: SEK 43.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 724.50
7D
0.6%
1Y
7.6%
AprilBioLtd
Market Cap: ₩574.3b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩25,450.00
7D
12.6%
1Y
28.0%
PharmaResearch
Market Cap: ₩6.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩630,000.00
7D
-7.4%
1Y
237.6%
Immutep
Market Cap: AU$344.9m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.23
7D
0%
1Y
-39.7%
Oscotec
Market Cap: ₩1.6t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩42,100.00
7D
14.6%
1Y
24.2%
Xbrane Biopharma
Market Cap: SEK 670.1m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.26
7D
-9.1%
1Y
99.4%
Bonesupport Holding
Market Cap: SEK 21.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 318.40
7D
2.6%
1Y
10.2%
PharmaEssentia
Market Cap: NT$170.0b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$510.00
7D
2.7%
1Y
-26.1%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥13.0b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥40.99
7D
-4.2%
1Y
-3.1%
argenx
Market Cap: €39.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€639.80
7D
5.9%
1Y
31.2%
Xiamen Amoytop Biotech
Market Cap: CN¥34.5b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥84.74
7D
2.0%
1Y
57.5%
EZZ Life Science Holdings
Market Cap: AU$103.8m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.20
7D
-6.4%
1Y
-22.8%
Legend Biotech
Market Cap: US$6.5b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$36.08
7D
3.9%
1Y
-25.3%
Cutia Therapeutics
Market Cap: HK$3.7b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$10.50
7D
-9.1%
1Y
-19.2%
Mesoblast
Market Cap: AU$2.7b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.12
7D
-2.8%
1Y
124.3%
Vanda Pharmaceuticals
Market Cap: US$274.2m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.61
7D
-2.5%
1Y
-8.2%
LENZ Therapeutics
Market Cap: US$1.1b
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$41.98
7D
8.7%
1Y
76.4%
Evoke Pharma
Market Cap: US$11.0m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.21
7D
-4.4%
1Y
34.6%
ARS Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$10.07
7D
-13.3%
1Y
-11.4%
Madrigal Pharmaceuticals
Market Cap: US$9.6b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$432.89
7D
-1.1%
1Y
77.5%
Soleno Therapeutics
Market Cap: US$3.7b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$69.77
7D
3.1%
1Y
43.7%
Achieve Life Sciences
Market Cap: US$142.6m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.83
7D
-5.0%
1Y
-32.1%
SKAN Group
Market Cap: CHF 1.3b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 58.30
7D
-5.0%
1Y
-26.0%
Alterity Therapeutics
Market Cap: AU$119.7m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.013
7D
-7.1%
1Y
333.3%
Beijing Luzhu Biotechnology
Market Cap: HK$4.8b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$24.04
7D
-2.4%
1Y
11.8%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥36.4b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥79.18
7D
3.2%
1Y
121.3%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.6b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥18.14
7D
-4.8%
1Y
48.3%
Boji Medical TechnologyLtd
Market Cap: CN¥4.1b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.82
7D
-0.6%
1Y
49.7%
ACADIA Pharmaceuticals
Market Cap: US$4.3b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$25.26
7D
-2.8%
1Y
57.2%
ADMA Biologics
Market Cap: US$4.0b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$16.87
7D
-2.3%
1Y
3.8%
Clinuvel Pharmaceuticals
Market Cap: AU$565.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.28
7D
5.9%
1Y
-23.4%
Eton Pharmaceuticals
Market Cap: US$479.2m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.67
7D
2.1%
1Y
285.0%
AC Immune
Market Cap: US$212.7m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.28
7D
11.8%
1Y
-23.7%